
Sonic Incytes flagship product, Velacurâ„¢, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the key markers for fatty liver disease: liver stiffness, attenuation. With real-time results, a low up-front cost and AI guidance, Velacur makes liver imaging at the point of care affordable and accessible.
Sonic Incytes Medical Corp.
309-1788 West 5th Avenue
Vancouver, BC V6J 1P2